Infections by Alloscardovia omnicolens and Associated Clinical Conditions: A Systematic Review
Abstract
Background and Aim: Alloscardovia omnicolens is a gram-positive, non-motile, non-sporulating bacillus that is occasionally identified as a member of the human microbiota. Despite its infrequent colonization of humans, it has been detected in various anatomical sites, including the gastrointestinal tract, urinary tract, vaginal mucosa, and oral cavity, and has the potential to cause opportunistic infections. This systematic literature review aims to analyze the pathogenic potential of A. omnicolens and the underlying clinical conditions associated with infection. Methods: A systematic review of scientific manuscripts was conducted using the PubMed, SciELO, and Google Scholar databases. The search terms employed included "Alloscardovia omnicolens," "infection" "culture," and "identification". Manuscripts published in English, Portuguese, Spanish, and French from 2007 to 2023 were considered for review. Results: Following the bibliographic selection process, a total of five articles discussing Alloscardovia omnicolens infections were included, along with an additional thirty-six articles for analytical support. Conclusion: Infections caused by Alloscardovia omnicolens are infrequent and are predominantly associated with underlying medical conditions. The detection of this bacterium in cultures of organic specimens from patients, particularly those with neoplastic diseases, warrants clinical attention when patients are in critical health states or exhibit risk factors for…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.